SCHEMBL30029922

SCHEMBL30029922

C[C@H](NC(=O)CNC(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.44
MAPT P10636 3/20 0.43
RECQL P46063 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
GAA P10253 1/20 0.41
TDP1 Q9NUW8 3/20 0.40
CTSS P25774 3/20 0.40
CTSK P43235 3/20 0.40
XBP1 P17861 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40
CA12 O43570 1/20 0.40
CA14 Q9ULX7 1/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23332499 1.00 NPSR1 (0.44) NPSR1MAPTRECQLL3MBTL1CA1
SCHEMBL29918164 0.93 NPSR1 (0.40) NPSR1MAPTRECQLL3MBTL1CA1
SCHEMBL16667763 0.92 CA12 (0.49) NPSR1MAPTRECQLL3MBTL1CA1
SCHEMBL8140353 0.87 KMT2A (0.49) CA1CA2CA7KMT2AMEN1
SCHEMBL31314679 0.87 KMT2A (0.49) CA1CA2CA7KMT2AMEN1
SCHEMBL8251498 0.84 CA1 (0.46) CA1CA2CA7KMT2AMEN1
SCHEMBL28339162 0.84 NPSR1 (0.35) NPSR1MAPTRECQLL3MBTL1CA1
SCHEMBL31069956 0.84 KMT2A (0.46) CA1CA2CA7KMT2AMEN1
SCHEMBL30029784 0.84 CTSK (0.48) CA1CA2CA7KMT2AMEN1
SCHEMBL9481173 0.82 CTSK (0.36) NPSR1MAPTRECQLL3MBTL1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4538279-A2 REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME Chubu University Educational Foundation (JP) 2025-04-16 EP disclosed
EP-4357353-A1 PEPTIDE COMPOUND PRODUCTION METHOD Chubu University Educational Foundation (JP) 2024-04-24 EP disclosed
US-20230121469-A1 CATALYST FOR MANUFACTURING AMIDE COMPOUND, AND METHOD FOR MANUFACTURING AMIDE COMPOUND CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) 2023-04-20 US disclosed
US-20230002422-A1 REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) 2023-01-05 US disclosed
WO-2022265115-A1 PEPTIDE COMPOUND PRODUCTION METHOD 学校法人中部大学 2022-12-22 WO disclosed
EP-4053132-A1 REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME Chubu University Educational Foundation (JP) 2022-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002422-A1 REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME NAAA, NOTUM, ASNS NPSR1 696/4885MAPT 4225/4885RECQL 4524/4885
US-20230121469-A1 CATALYST FOR MANUFACTURING AMIDE COMPOUND, AND METHOD FOR MANUFACTURING AMIDE COMPOUND NAAA, ASNS, BCAT2 NPSR1 1711/4885MAPT 3585/4885RECQL 4336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.